{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:34:34Z","timestamp":1785483274631,"version":"3.56.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL126825"],"award-info":[{"award-number":["R01HL126825"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL146111"],"award-info":[{"award-number":["R01HL146111"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL153835"],"award-info":[{"award-number":["R01HL153835"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL126825"],"award-info":[{"award-number":["R01HL126825"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL153835"],"award-info":[{"award-number":["R01HL153835"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL146111"],"award-info":[{"award-number":["R01HL146111"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1038\/s41434-022-00321-w","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T03:04:54Z","timestamp":1643684694000},"page":"543-551","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Targeting mAKAP\u03b2 expression as a therapeutic approach for ischemic cardiomyopathy"],"prefix":"10.1038","volume":"30","author":[{"given":"Eliana C.","family":"Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Arthur","family":"Ataam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Tokarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrishikesh","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Karakikes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Dodge-Kafka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7005-6953","authenticated-orcid":false,"given":"Michael S.","family":"Kapiloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"key":"321_CR1","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","volume":"143","author":"SS Virani","year":"2021","unstructured":"Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart Disease and Stroke Statistics-2021 update: a report From the American Heart Association. Circulation. 2021;143:e254\u2013e743.","journal-title":"Circulation."},{"key":"321_CR2","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599\u2013726.","journal-title":"Eur Heart J."},{"key":"321_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15:387\u2013407.","journal-title":"Nat Rev Cardiol."},{"key":"321_CR4","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.tips.2020.09.007","volume":"41","author":"MH Omar","year":"2020","unstructured":"Omar MH, Scott JD. AKAP signaling islands: venues for precision pharmacology. Trends Pharmacol Sci. 2020;41:933\u201346.","journal-title":"Trends Pharmacol Sci."},{"key":"321_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ppedcard.2007.11.012","volume":"25","author":"A Negro","year":"2008","unstructured":"Negro A, Dodge-Kafka K, Kapiloff MS. Signalosomes as therapeutic targets. Prog Pediatr Cardiol. 2008;25:51\u20136.","journal-title":"Prog Pediatr Cardiol."},{"key":"321_CR6","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1124\/pharmrev.120.000086","volume":"73","author":"M Zaccolo","year":"2021","unstructured":"Zaccolo M, Zerio A, Lobo MJ. Subcellular organization of the cAMP signaling pathway. Pharmacol Rev. 2021;73:278\u2013309.","journal-title":"Pharmacol Rev."},{"key":"321_CR7","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1161\/CIRCULATIONAHA.119.044805","volume":"142","author":"J Li","year":"2020","unstructured":"Li J, Tan Y, Passariello CL, Martinez EC, Kritzer MD, Li X, et al. Signalosome-regulated serum response factor phosphorylation determining myocyte growth in width versus length as a therapeutic target for heart failure. Circulation. 2020;142:2138\u201354.","journal-title":"Circulation."},{"key":"321_CR8","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1161\/CIRCULATIONAHA.119.044893","volume":"142","author":"X Li","year":"2020","unstructured":"Li X, Li J, Martinez EC, Froese A, Passariello CL, Henshaw K, et al. Calcineurin Abeta-specific anchoring confers isoform-specific compartmentation and function in pathological cardiac myocyte hypertrophy. Circulation. 2020;142:948\u201362.","journal-title":"Circulation."},{"key":"321_CR9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1161\/CIRCHEARTFAILURE.114.001266","volume":"7","author":"MD Kritzer","year":"2014","unstructured":"Kritzer MD, Li J, Passariello CL, Gayanilo M, Thakur H, Dayan J, et al. The scaffold protein muscle A-kinase anchoring protein beta orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure. Circ Heart Fail. 2014;7:663\u201372.","journal-title":"Circ Heart Fail."},{"key":"321_CR10","doi-asserted-by":"publisher","first-page":"e012239","DOI":"10.1161\/JAHA.119.012239","volume":"8","author":"JM Kieserman","year":"2019","unstructured":"Kieserman JM, Myers VD, Dubey P, Cheung JY, Feldman AM. Current landscape of heart failure gene therapy. J Am Heart Assoc. 2019;8:e012239.","journal-title":"J Am Heart Assoc."},{"key":"321_CR11","doi-asserted-by":"publisher","first-page":"109357","DOI":"10.1016\/j.cellsig.2019.109357","volume":"63","author":"K Dodge-Kafka","year":"2019","unstructured":"Dodge-Kafka K, Gildart M, Tokarski K, Kapiloff MS. mAKAPbeta signalosomes\u2013A nodal regulator of gene transcription associated with pathological cardiac remodeling. Cell Signal. 2019;63:109357.","journal-title":"Cell Signal."},{"key":"321_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.yexcr.2012.12.016","volume":"319","author":"J Li","year":"2013","unstructured":"Li J, Vargas MA, Kapiloff MS, Dodge-Kafka KL. Regulation of MEF2 transcriptional activity by calcineurin\/mAKAP complexes. Exp Cell Res. 2013;319:447\u201354.","journal-title":"Exp Cell Res."},{"key":"321_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.yjmcc.2009.10.023","volume":"48","author":"J Li","year":"2010","unstructured":"Li J, Negro A, Lopez J, Bauman AL, Henson E, Dodge-Kafka K, et al. The mAKAPbeta scaffold regulates cardiac myocyte hypertrophy via recruitment of activated calcineurin. J Mol Cell Cardiol. 2010;48:387\u201394.","journal-title":"J Mol Cell Cardiol."},{"key":"321_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.yjmcc.2018.03.001","volume":"118","author":"KL Dodge-Kafka","year":"2018","unstructured":"Dodge-Kafka KL, Gildart M, Li J, Thakur H, Kapiloff MS. Bidirectional regulation of HDAC5 by mAKAPbeta signalosomes in cardiac myocytes. J Mol Cell Cardiol. 2018;118:13\u201325.","journal-title":"J Mol Cell Cardiol."},{"key":"321_CR15","doi-asserted-by":"publisher","first-page":"ra18","DOI":"10.1126\/scisignal.2000026","volume":"1","author":"W Wong","year":"2008","unstructured":"Wong W, Goehring AS, Kapiloff MS, Langeberg LK, Scott JD. mAKAP compartmentalizes oxygen-dependent control of HIF-1alpha. Sci Signal. 2008;1:ra18.","journal-title":"Sci Signal."},{"key":"321_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/hh1301.092687","volume":"89","author":"DS Sohal","year":"2001","unstructured":"Sohal DS, Nghiem M, Crackower MA, Witt SA, Kimball TR, Tymitz KM, et al. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res. 2001;89:20\u20135.","journal-title":"Circ Res."},{"key":"321_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/gt.2010.105","volume":"18","author":"KM Prasad","year":"2011","unstructured":"Prasad KM, Xu Y, Yang Z, Acton ST, French BA. Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution. Gene Ther. 2011;18:43\u201352.","journal-title":"Gene Ther."},{"key":"321_CR18","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/ng1650","volume":"37","author":"JM Silva","year":"2005","unstructured":"Silva JM, Li MZ, Chang K, Ge W, Golding MC, Rickles RJ, et al. Second-generation shRNA libraries covering the mouse and human genomes. Nat Genet. 2005;37:1281\u20138.","journal-title":"Nat Genet."},{"key":"321_CR19","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1038\/sj.gt.3302133","volume":"10","author":"Z Wang","year":"2003","unstructured":"Wang Z, Ma HI, Li J, Sun L, Zhang J, Xiao X. Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther. 2003;10:2105\u201311.","journal-title":"Gene Ther."},{"key":"321_CR20","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1242\/jcs.02675","volume":"118","author":"GC Pare","year":"2005","unstructured":"Pare GC, Bauman AL, McHenry M, Michel JJ, Dodge-Kafka KL, Kapiloff MS. The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling. J Cell Sci. 2005;118:5637\u201346.","journal-title":"J Cell Sci."},{"key":"321_CR21","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1242\/jcs.112.16.2725","volume":"112","author":"MS Kapiloff","year":"1999","unstructured":"Kapiloff MS, Schillace RV, Westphal AM, Scott JD. mAKAP: an A-kinase anchoring protein targeted to the nuclear membrane of differentiated myocytes. J Cell Sci. 1999;112:2725\u201336.","journal-title":"J Cell Sci."},{"key":"321_CR22","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1161\/CIRCULATIONAHA.120.049844","volume":"144","author":"DAM Feyen","year":"2021","unstructured":"Feyen DAM, Perea-Gil I, Maas RGC, Harakalova M, Gavidia AA, Arthur Ataam J, et al. Unfolded protein response as a compensatory mechanism and potential therapeutic target in PLN R14del Cardiomyopathy. Circulation. 2021;144:382\u201392.","journal-title":"Circulation."},{"key":"321_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/d41573-021-00017-7","volume":"20","author":"DA Kuzmin","year":"2021","unstructured":"Kuzmin DA, Shutova MV, Johnston NR, Smith OP, Fedorin VV, Kukushkin YS, et al. The clinical landscape for AAV gene therapies. Nat Rev Drug Discov. 2021;20:173\u20134.","journal-title":"Nat Rev Drug Discov."},{"key":"321_CR24","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/jgm.2673","volume":"14","author":"PR Konkalmatt","year":"2012","unstructured":"Konkalmatt PR, Wang F, Piras BA, Xu Y, O\u2019Connor DM, Beyers RJ, et al. Adeno-associated virus serotype 9 administered systemically after reperfusion preferentially targets cardiomyocytes in the infarct border zone with pharmacodynamics suitable for the attenuation of left ventricular remodeling. J Gene Med. 2012;14:609\u201320.","journal-title":"J Gene Med."},{"key":"321_CR25","doi-asserted-by":"publisher","first-page":"e61669","DOI":"10.7554\/eLife.61669","volume":"9","author":"S Vergarajauregui","year":"2020","unstructured":"Vergarajauregui S, Becker R, Steffen U, Sharkova M, Esser T, Petzold J, et al. AKAP6 orchestrates the nuclear envelope microtubule-organizing center by linking golgi and nucleus via AKAP9. Elife. 2020;9:e61669.","journal-title":"Elife"},{"key":"321_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cell.2020.03.023","volume":"181","author":"D Wang","year":"2020","unstructured":"Wang D, Zhang F, Gao G. CRISPR-based therapeutic genome editing: strategies and in vivo delivery by AAV vectors. Cell. 2020;181:136\u201350.","journal-title":"Cell."},{"key":"321_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/cvr\/cvs109","volume":"94","author":"D Fraccarollo","year":"2012","unstructured":"Fraccarollo D, Galuppo P, Bauersachs J. Novel therapeutic approaches to post-infarction remodelling. Cardiovasc Res. 2012;94:293\u2013303.","journal-title":"Cardiovasc Res."},{"key":"321_CR28","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1002\/cphy.c150006","volume":"5","author":"NG Frangogiannis","year":"2015","unstructured":"Frangogiannis NG. Pathophysiology of myocardial infarction. Compr Physiol. 2015;5:1841\u201375.","journal-title":"Compr Physiol."},{"key":"321_CR29","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1161\/01.CIR.101.25.2981","volume":"101","author":"MG Sutton","year":"2000","unstructured":"Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 2000;101:2981\u20138.","journal-title":"Circulation."},{"key":"321_CR30","doi-asserted-by":"publisher","first-page":"H422","DOI":"10.1152\/ajpheart.2000.279.1.H422","volume":"279","author":"F Sam","year":"2000","unstructured":"Sam F, Sawyer DB, Chang DL, Eberli FR, Ngoy S, Jain M, et al. Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol Heart Circ Physiol. 2000;279:H422\u20138.","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"321_CR31","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0735-1097(02)02959-5","volume":"41","author":"A Abbate","year":"2003","unstructured":"Abbate A, Biondi-Zoccai GG, Bussani R, Dobrina A, Camilot D, Feroce F, et al. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. J Am Coll Cardiol. 2003;41:753\u201360.","journal-title":"J Am Coll Cardiol."},{"key":"321_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/01.RES.0000107197.99679.77","volume":"94","author":"OF Bueno","year":"2004","unstructured":"Bueno OF, Lips DJ, Kaiser RA, Wilkins BJ, Dai YS, Glascock BJ, et al. Calcineurin Abeta gene targeting predisposes the myocardium to acute ischemia-induced apoptosis and dysfunction. Circ Res. 2004;94:91\u20139.","journal-title":"Circ Res."},{"key":"321_CR33","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1161\/01.CIR.0000127126.73759.23","volume":"109","author":"DJ Lips","year":"2004","unstructured":"Lips DJ, Bueno OF, Wilkins BJ, Purcell NH, Kaiser RA, Lorenz JN, et al. MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. Circulation. 2004;109:1938\u201341.","journal-title":"Circulation."},{"key":"321_CR34","doi-asserted-by":"publisher","first-page":"22295","DOI":"10.1074\/jbc.M801296200","volume":"283","author":"M Bourajjaj","year":"2008","unstructured":"Bourajjaj M, Armand AS, da Costa Martins PA, Weijts B, van der Nagel R, Heeneman S, et al. NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure. J Biol Chem. 2008;283:22295\u2013303.","journal-title":"J Biol Chem."},{"key":"321_CR35","doi-asserted-by":"publisher","first-page":"7603","DOI":"10.1128\/MCB.22.21.7603-7613.2002","volume":"22","author":"BJ Wilkins","year":"2002","unstructured":"Wilkins BJ, De Windt LJ, Bueno OF, Braz JC, Glascock BJ, Kimball TF, et al. Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth. Mol Cell Biol. 2002;22:7603\u201313.","journal-title":"Mol Cell Biol."},{"key":"321_CR36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1172\/JCI33255","volume":"118","author":"Y Kim","year":"2008","unstructured":"Kim Y, Phan D, van Rooij E, Wang DZ, McAnally J, Qi X, et al. The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. J Clin Invest. 2008;118:124\u201332.","journal-title":"J Clin Invest."},{"key":"321_CR37","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1074\/jbc.RA118.005465","volume":"294","author":"J Li","year":"2019","unstructured":"Li J, Aponte Paris S, Thakur H, Kapiloff MS, Dodge-Kafka KL. Muscle A-kinase-anchoring protein-beta-bound calcineurin toggles active and repressive transcriptional complexes of myocyte enhancer factor 2D. J Biol Chem. 2019;294:2543\u201354.","journal-title":"J Biol Chem."},{"key":"321_CR38","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cell.2013.02.047","volume":"153","author":"L Zhang","year":"2013","unstructured":"Zhang L, Malik S, Pang J, Wang H, Park KM, Yule DI, et al. Phospholipase Cepsilon hydrolyzes perinuclear phosphatidylinositol 4-phosphate to regulate cardiac hypertrophy. Cell. 2013;153:216\u201327.","journal-title":"Cell."},{"key":"321_CR39","doi-asserted-by":"publisher","first-page":"11078","DOI":"10.1074\/jbc.M109.034868","volume":"285","author":"KL Dodge-Kafka","year":"2010","unstructured":"Dodge-Kafka KL, Bauman A, Mayer N, Henson E, Heredia L, Ahn J, et al. cAMP-stimulated protein phosphatase 2A activity associated with muscle A kinase-anchoring protein (mAKAP) signaling complexes inhibits the phosphorylation and activity of the cAMP-specific phosphodiesterase PDE4D3. J Biol Chem. 2010;285:11078\u201386.","journal-title":"J Biol Chem."},{"key":"321_CR40","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.yexcr.2004.10.009","volume":"303","author":"GC Pare","year":"2005","unstructured":"Pare GC, Easlick JL, Mislow JM, McNally EM, Kapiloff MS. Nesprin-1alpha contributes to the targeting of mAKAP to the cardiac myocyte nuclear envelope. Exp Cell Res. 2005;303:388\u201399.","journal-title":"Exp Cell Res."},{"key":"321_CR41","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1161\/CIRCHEARTFAILURE.108.814459","volume":"2","author":"JA Dixon","year":"2009","unstructured":"Dixon JA, Spinale FG. Large animal models of heart failure: a critical link in the translation of basic science to clinical practice. Circ Heart Fail. 2009;2:262\u201371.","journal-title":"Circ Heart Fail."}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00321-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00321-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00321-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T14:02:54Z","timestamp":1692972174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00321-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":41,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["321"],"URL":"https:\/\/doi.org\/10.1038\/s41434-022-00321-w","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"13 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal research was approved by the Institutional Animal Care and Use Committee at the University of Miami and the University of Connecticut. The Stanford University Institutional Review Board approved the use of pluripotent stem cells.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Drs. Kapiloff and Li are inventors of patent-protected intellectual property concerning the targeting of mAKAP\u03b2 signalosomes to treat heart failure, by which they, the University of Miami, and Stanford University may gain royalties from future commercialization. Dr. Kapiloff holds equity in Anchored RSK3 Inhibitors, LLC, and Cardiac RSK3 Inhibitors, LLC, companies interested in developing mAKAP signalosome-targeted therapies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}